Study to Investigate the Safety, Tolerability and Pharmacokinetics of QEV-817 Oral Suspension

Clinical trial NCT06585163 · COMPLETED

Trial details

NCT number: NCT06585163
Sponsor: Quivive Pharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy PK Drug-drug Interaction Study

Start date: 2025-08-18
Primary completion: 2025-08-29
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.